Stock Taper
CON
CONCENTRA GROUP HOLDINGS PARENT, INC.
NYSE
$37.19
▲ UP 1.58% (0.58)

KEY STATISTICS

Market Cap$4.69 B
52w High$37.26
52w Low$18.55
Dividend Yield0.73%
FrequencyQuarterly
P/E23.39
Volume778.32K
Shares Out.127.96M

COMPANY

LEADERSHIP

William Keith Newton
CHIEF EXECUTIVE
William Keith Newton

COMPENSATION 2026

Salary$843,077
Stock Awards$4,356,000
Incentive Plan Pay$2,125,000
All Other Comp.$75,436
Total$7,399,513

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 25, 2024
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
9,983

PRICE TARGET

Target High$42.00
Target Low$30.00
Target Median$40.00
Target Consensus$38.60

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$605.24M
NOV
5
THU

ETFS HOLDING THIS STOCK

ETFS HOLDING
204
LISTED HERE
10
RANKED BY POSITION SIZE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
54.82%
HOLDERS
370
TOP 8 OF 370 · RANKED BY POSITION SIZE

PRICE

$37.19 ▲ UP 1.58% (+$0.58)
$36.30$36.60$36.90$37.209:32 AM10:37 AM11:41 AM12:46 PM1:50 PM2:54 PM3:59 PM37.19

About Concentra Group Holdings Parent, Inc.

https://www.concentra.com ↗

Concentra Group Holdings Parent, Inc. provides comprehensive occupational health services, including urgent care, testing, telemedicine, pharmacy, and employer solutions across the U.S., and is a subsidiary of Select Medical Corporation.

INDUSTRY

Medical - Care Facilities

A SERVICE CONCENTRA GROUP HOLDINGS PARENT, INC. IS KNOWN FOR

Occupational Health Services

Concentra is a leading U.S. provider of occupational health services, offering treatment for work-related injuries, physical therapy, pre-employment screenings, and drug testing to improve workforce health.

Concentra Group Holdings Parent in 2025

SENTIMENT: + POSITIVE
Matt DiCanio
ACQUISITION · JANUARY 2025

Concentra's Strategic Acquisition of Nova Medical Centers Fuels Aggressive Growth and Positive 2025 Outlook

Concentra Group Holdings Parent, Inc. made a significant strategic move by announcing its agreement to acquire Nova Medical Centers for $265 million in January 2025. This acquisition, along with the subsequent purchase of Pivot Onsite Innovations, substantially expanded Concentra's national footprint and was a primary catalyst for the company repeatedly raising its financial guidance throughout 2025. The move was met with positive reactions from market analysts, who viewed it as a key driver for future revenue and earnings growth.

ACQUISITION · APRIL 2025 · COMPLETED

Concentra Doubles Down on Employer Onsite Health with Acquisition of Pivot Onsite Innovations

Concentra acquired Pivot Onsite Innovations, a move that doubled the size of its onsite health clinics business. This strategic acquisition significantly expands Concentra's footprint in providing healthcare services directly at employer locations, a key growth area for the company.

Latest News

BUSINESS WIRE · OCT 8, 2026

Concentra to Announce Third Quarter 2026 Results on Thursday, November 5, 2026

DALLAS--(BUSINESS WIRE)--Concentra® Group Holdings Parent, Inc. (“Concentra”) (NYSE: CON) will release the financial results for its third quarter ended September 30, 2026, on Thursday, November 5, 2026, after the market closes. Concentra will host a conference call regarding its financial results on Friday, November 6, 2026, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's website at https://ir.concent.

EARLIER COVERAGE
ZACKS INVESTMENT RESEARCH · OCT 7, 2026

Concentra Group Holdings Parent, Inc. (CON) Hit a 52 Week High, Can the Run Continue?

Concentra (CON) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

DEFENSE WORLD · OCT 6, 2026

Concentra Group Holdings Parent (NYSE:CON) Reaches New 52-Week High – Here’s Why

Concentra Group Holdings Parent, Inc. (NYSE: CON - Get Free Report)'s stock price hit a new 52-week high during trading on Tuesday. The company traded as high as $36.83 and last traded at $36.37, with a volume of 37068 shares trading hands. The stock had previously closed at $36.21. Analyst Upgrades and Downgrades CON has been

MARKETBEAT · OCT 2, 2026

Why Concentra's Quiet Healthcare Business Keeps Winning

The company is growing, widening its margins, paying down debt, and paying a dividend all at the same time. Wall Street sees more upside ahead and has tagged the stock with a full Buy rating.

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity5
Return On Assets5
Debt To Equity1
Price To Earnings3
Price To Book1
Overall Score3

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OVERWEIGHT 2
BUY 2
OUTPERFORM 1
5 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
HAE$118.11COMPARE
ITGR$126.68COMPARE
BEAM$24.38COMPARE
HCM$13.62COMPARE
BHC$6.08COMPARE
PBH$47.55COMPARE
ADUS$115.38COMPARE
XRAY$8.48COMPARE

TRADES BY CONGRESS

HOUSE TRADES
Lisa C. McClain
Lisa C. McClain
Sale (Full)
2025-09-25
Lisa McClain
Lisa McClain
Sale (Full)
2025-09-25

INSIDER TRADES

★
DIRECTOR
ORTENZIO ROBERT A
Sale · 770.0K shares
2026-08-21
★
DIRECTOR
ORTENZIO ROBERT A
Sale · 30.0K shares
2026-08-21
★
DIRECTOR
ORTENZIO ROBERT A
Sale · 20.0K shares
2026-08-21
★
DIRECTOR
ORTENZIO ROBERT A
Sale · 150.0K shares
2026-08-21